Diabetic Retinopathy Market Size, Share, Growth Analysis, By Type(Proliferative Diabetic Retinopathy, and Non-proliferative diabetic retinopathy), By Management(Anti-VEGF, Intraocular Steroid Injection, Laser Surgery, and Vitrectomy), By Region - Industry Forecast 2024-2031

The increasing global prevalence of diabetes is a significant driver for the diabetic retinopathy market. Diabetic retinopathy is a common complication of diabetes and affects many diabetic patients. The growing diabetic population contributes to the demand for diagnostic and treatment options for diabetic retinopathy. 

Better facilities and equipment are made possible by more funding. Among those with the necessary tools to identify and manage diabetic retinopathy are ophthalmology departments. A larger market for diabetic retinopathy may result from increased screening and treatment of more patients with stronger infrastructure.

Despite the growing prevalence of diabetic retinopathy, there is a lack of awareness about the condition and the importance of regular eye examinations among diabetic patients. Limited access to eye care facilities, particularly in remote or underserved areas, hampers early detection and timely treatment.

Developing economies face a double challenge in addressing diabetic retinopathy. Firstly, a scarcity of skilled professionals like ophthalmologists exists. This limits the capacity to diagnose and treat the condition effectively. Secondly, weak healthcare infrastructure translates to a lack of specialized equipment and facilities needed for proper diabetic retinopathy care. These factors combine to restrict the growth of the diabetic retinopathy market in these regions.